Endosymbiotic theory

Endosymbiotic theory is a scientific theory that explains the origin of eukaryotic cells from prokaryotes. It states that certain organelles, especially mitochondria and plastids, were originally free-living bacteria that were taken inside another cell as endosymbionts. Over time, these endosymbionts and the host cell became mutually beneficial to each other, leading to a permanent relationship. This theory is widely accepted in the scientific community due to the numerous pieces of supporting evidence.

History

The endosymbiotic theory was first proposed in the early 20th century by Russian botanist Konstantin Mereschkowski. However, it was not widely accepted until the 1960s when American biologist Lynn Margulis provided further evidence and promoted the theory.

Evidence

There are several pieces of evidence that support the endosymbiotic theory. These include:

• Genetic Evidence: Mitochondria and plastids have their own DNA, which is separate from the nuclear DNA of the cell. This DNA is circular and resembles the DNA of bacteria, suggesting a bacterial origin.

• Structural Evidence: The structure of mitochondria and plastids is similar to that of bacteria. They have a double membrane and their own ribosomes, which are more similar to bacterial ribosomes than to eukaryotic ribosomes.

• Functional Evidence: Mitochondria and plastids reproduce independently of the cell, using a process similar to bacterial binary fission.

Implications

The endosymbiotic theory has significant implications for our understanding of evolution. It suggests that cooperation and mutual benefit can be important drivers of evolution, in addition to competition and natural selection. It also provides a plausible explanation for the origin of eukaryotic cells, which are more complex and versatile than prokaryotic cells.

See Also

• Cell biology
• Evolution
• Mitochondria
• Plastids

References

Endosymbiotic theory Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.